RicercaInizia una nuova ricerca
NOTA: è possibile cercare una corrispondenza esatta usando i doppi apici, ad es: "evoluzione della specie". Qualora si cerchi un identificativo, è consigliabile cercarlo in due modi differenti: tra apici con caratteri speciali es: "978-94-6366-274" oppure senza caratteri speciali solo come sequenza numerica: es 978946366274.
Nonsmall cell lung cancer in never smokers
2009-01-01 Scagliotti G.V.; Longo M; Novello S.
Novel investigational therapies for treating biliary tract carcinoma
2016-01-01 Tampellini, M; La Salvia, A; Scagliotti, Gv
Nucleotide excision repair pathways involved in cisplatin resistance in non-small-cell lung cancer
2003-01-01 Rosell, Rafael; Taron, Miquel; Barnadas, Agusti; Scagliotti, Giorgio; Sarries, Carme; Roig, Barbara
Ocular metastases from neuroendocrine tumors: A literature review
2020-01-01 La Salvia A.; Persano I.; Trevisi E.; Parlagreco E.; Muratori L.; Scagliotti G.V.; Brizzi M.P.
Ongoing and future trials of biologic therapies in lung cancer
2003-01-01 Bunn, Paul A; Shepherd, Frances A; Sandler, Alan; Le Chevalier, Thierry; Belani, Chandra P; Kosmidis, Paris A; Scagliotti, Giorgio V; Giaccone, Giuseppe
Optimizing the clinical management of EGFR-mutant advanced non-small cell lung cancer: a literature review
2022-01-01 Passiglia, Francesco; Bironzo, Paolo; Bertaglia, Valentina; Listì, Angela; Garbo, Edoardo; Scagliotti, Giorgio Vittorio
Pathological characterization of tumor immune microenvironment (Time) in malignant pleural mesothelioma
2021-01-01 Napoli F.; Listi A.; Zambelli V.; Witel G.; Bironzo P.; Papotti M.; Volante M.; Scagliotti G.; Righi L.
PD-1 receptor outside the main paradigm: tumour-intrinsic role and clinical implications for checkpoint blockade
2023-01-01 Donini, C; Galvagno, F; Rotolo, R; Massa, A; Merlini, A; Scagliotti, G V; Novello, S; Bironzo, P; Leuci, V; Sangiolo, D
Pharmacogenomic strategies for developing customized chemotherapy in non-small cell lung cancer
2002-01-01 Sarries, Carme; Haura, Eric B.; Roig, Barbara; Taron, Miquel; Abad, Albert; Scagliotti, Giorgio; Rosell, Rafael*
Primary Pleuropulmonary Sarcoma: A Rare Disease Entity.
2012-01-01 Giaj Levra M; Novello S; Scagliotti GV; Papotti M; Le Cesne A.
Titolo | Data di pubblicazione | Autore(i) | File |
---|---|---|---|
Nonsmall cell lung cancer in never smokers | 2009 | Scagliotti G.V.; Longo M; Novello S. | |
Novel investigational therapies for treating biliary tract carcinoma | 2016 | Tampellini, M; La Salvia, A; Scagliotti, Gv | |
Nucleotide excision repair pathways involved in cisplatin resistance in non-small-cell lung cancer | 2003 | Rosell, Rafael; Taron, Miquel; Barnadas, Agusti; Scagliotti, Giorgio; Sarries, Carme; Roig, Barbara | |
Ocular metastases from neuroendocrine tumors: A literature review | 2020 | La Salvia A.; Persano I.; Trevisi E.; Parlagreco E.; Muratori L.; Scagliotti G.V.; Brizzi M.P. | |
Ongoing and future trials of biologic therapies in lung cancer | 2003 | Bunn, Paul A; Shepherd, Frances A; Sandler, Alan; Le Chevalier, Thierry; Belani, Chandra P; Kosmidis, Paris A; Scagliotti, Giorgio V; Giaccone, Giuseppe | |
Optimizing the clinical management of EGFR-mutant advanced non-small cell lung cancer: a literature review | 2022 | Passiglia, Francesco; Bironzo, Paolo; Bertaglia, Valentina; Listì, Angela; Garbo, Edoardo; Scagliotti, Giorgio Vittorio | |
Pathological characterization of tumor immune microenvironment (Time) in malignant pleural mesothelioma | 2021 | Napoli F.; Listi A.; Zambelli V.; Witel G.; Bironzo P.; Papotti M.; Volante M.; Scagliotti G.; Righi L. | |
PD-1 receptor outside the main paradigm: tumour-intrinsic role and clinical implications for checkpoint blockade | 2023 | Donini, C; Galvagno, F; Rotolo, R; Massa, A; Merlini, A; Scagliotti, G V; Novello, S; Bironzo, P; Leuci, V; Sangiolo, D | |
Pharmacogenomic strategies for developing customized chemotherapy in non-small cell lung cancer | 2002 | Sarries, Carme; Haura, Eric B.; Roig, Barbara; Taron, Miquel; Abad, Albert; Scagliotti, Giorgio; Rosell, Rafael* | |
Primary Pleuropulmonary Sarcoma: A Rare Disease Entity. | 2012 | Giaj Levra M; Novello S; Scagliotti GV; Papotti M; Le Cesne A. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Opzioni
Scopri
Tipologia
- 03-CONTRIBUTO IN RIVISTA 65
- 03-CONTRIBUTO IN RIVISTA::03B-Rev... 65
Data di pubblicazione
- 2020 - 2024 27
- 2010 - 2019 23
- 2000 - 2009 13
- 1995 - 1999 2
Rivista
- CANCER TREATMENT REVIEWS 7
- JOURNAL OF THORACIC ONCOLOGY 7
- LUNG CANCER 6
- CRITICAL REVIEWS IN ONCOLOGY HEMA... 5
- CLINICAL LUNG CANCER 3
- FUTURE ONCOLOGY 3
- SEMINARS IN ONCOLOGY 3
- ENDOCRINE-RELATED CANCER 2
- EXPERT REVIEW OF ANTICANCER THERAPY 2
- TRANSLATIONAL LUNG CANCER RESEARCH 2
Keyword
- Humans 21
- Carcinoma 16
- Lung Neoplasms 16
- Non-Small-Cell Lung 15
- Oncology 9
- Antineoplastic Agents 7
- Antineoplastic Combined Chemother... 7
- Cisplatin 7
- Biomarkers 4
- Clinical Trials as Topic 4
Lingua
- eng 64
- ita 1
Accesso al fulltext
- reserved 30
- open 18
- no fulltext 12
- partially open 5